{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:45:28Z","timestamp":1776851128986,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001125","name":"GAVI Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T20:55:09Z","timestamp":1587416109000},"page":"3922-3929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010\u20132018"],"prefix":"10.1016","volume":"38","author":[{"given":"Sani","family":"Ousmane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issaka","family":"Seidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassira","family":"Issaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sable","family":"Sharpley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia G.","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahamoudou","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.04.009_b0005","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.vaccine.2007.04.032","article-title":"Meningitis epidemics in Africa: a brief overview","volume":"25","author":"Teyssou","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.04.009_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","article-title":"Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa","volume":"96","author":"Molesworth","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.04.009_b0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(07)70288-8","article-title":"Meningococcal carriage in the African meningitis belt","volume":"7","author":"Trotter","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2020.04.009_b0020","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004\u20132013","volume":"61","author":"Lingani","year":"2015","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America."},{"key":"10.1016\/j.vaccine.2020.04.009_b0025","unstructured":"MenAfriNet. Surveillance Feedback Bulletins."},{"key":"10.1016\/j.vaccine.2020.04.009_b0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S1473-3099(16)30253-5","article-title":"Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data","volume":"16","author":"Sidikou","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.009_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052464","article-title":"Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults","volume":"7","author":"Mueller","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.009_b0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/431151","article-title":"An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics","volume":"192","author":"Leimkugel","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.009_b0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-10-22","article-title":"African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults","volume":"10","author":"Gessner","year":"2010","journal-title":"BMC Infect Dis."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.04.009_b0050","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.vaccine.2007.04.036","article-title":"Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better","volume":"25","author":"Boisier","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.04.009_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060432","article-title":"Determination of pneumococcal serotypes in meningitis cases in Niger, 2003\u20132011","volume":"8","author":"Collard","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.009_b0060","first-page":"85","article-title":"Pneumococcal Conjugate Vaccines in Infants and Children Under 5 Years of Age: WHO Position Paper - February 2019","volume":"8","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.04.009_b0065","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/INF.0000000000000076","article-title":"Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers","volume":"33","author":"Whitney","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.009_b0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-3156.2005.01394.x","article-title":"Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135","volume":"10","author":"Boisier","year":"2005","journal-title":"Tropical medicine & international health : TM & IH."},{"key":"10.1016\/j.vaccine.2020.04.009_b0075","author":"World Health Organization","year":"2011","journal-title":"Standard Operating Procedures for Enhanced Meningitis Surveillance in Africa: African 'Meningitis Belt'"},{"key":"10.1016\/j.vaccine.2020.04.009_b0080","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3201\/eid0911.030462","article-title":"Polymerase chain reaction assay and bacterial meningitis surveillance in remote reas, Niger","volume":"9","author":"Sidikou","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.009_b0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.trstmh.2005.09.006","article-title":"Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger","volume":"100","author":"Chanteau","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.04.009_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147765","article-title":"Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction","volume":"11","author":"Vuong","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.009_b0095","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1093\/infdis\/jiz296","article-title":"Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010\u20132018","volume":"220","author":"Sidikou","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.009_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203205","article-title":"Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine","volume":"13","author":"Bozio","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.009_b0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/JCM.02927-12","article-title":"Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden","volume":"51","author":"Pimenta","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.009_b0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential Multiplex PCR Approach for Determining Capsular Serotypes of Streptococcus pneumoniae Isolates","volume":"44","author":"Pai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.009_b0115","unstructured":"Centers for Disease Control and Prevention. Streptococcus Laboratory. Resources and Protocols."},{"key":"10.1016\/j.vaccine.2020.04.009_b0120","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA","volume":"45","author":"Carvalho","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.009_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166384","article-title":"Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011\u20132013","volume":"11","author":"Kambire","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.009_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169547","article-title":"Serotype Distribution and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy Toddlers before PCV13 Introduction in Niamey, Niger","volume":"12","author":"Ousmane","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.009_b0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jinf.2017.12.002","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014\u20132015","volume":"76","author":"Kambire","year":"2018","journal-title":"J Infect."},{"key":"10.1016\/j.vaccine.2020.04.009_b0140","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/jiz358","article-title":"Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015\u20132017","volume":"220","author":"Soeters","year":"2019","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2020.04.009_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/fmb.11.146","article-title":"What is different about serotype 1 pneumococci?","volume":"7","author":"Ritchie","year":"2012","journal-title":"Future microbiology."},{"key":"10.1016\/j.vaccine.2020.04.009_b0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/CVI.00758-14","article-title":"Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies","volume":"22","author":"Blumental","year":"2015","journal-title":"Clinical and vaccine immunology : CVI."},{"key":"10.1016\/j.vaccine.2020.04.009_b0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12879-016-1914-3","article-title":"An outbreak of pneumococcal meningitis among older children (>\/=5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana","volume":"16","author":"Kwambana-Adams","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.04.009_b0160","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/INF.0000000000000083","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage","volume":"33","author":"Fleming-Dutra","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.009_b0165","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"The Lancet Global health."},{"key":"10.1016\/j.vaccine.2020.04.009_b0170","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2017.12.069","article-title":"Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana","volume":"37","author":"Cooper","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.04.009_b0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.009_b0180","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/infdis\/jiz336","article-title":"Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018","volume":"220","author":"Bwaka","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.009_b0185","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u201396","volume":"77","author":"Campagne","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.04.009_b0190","article-title":"la Statistique Republique du Niger. Etat et Structure de la Population du Niger en 2012","author":"Institut National de","year":"2015","journal-title":"Institut National de la Statistique"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:01Z","timestamp":1759401781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":38,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304680"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010\u20132018","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}